Page last updated: 2024-08-21

butenolide and Carcinoma, Pancreatic Ductal

butenolide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Gao, W; Guan, D; Hu, Z; Lai, Y; Liu, M; Qi, C; Wang, J; Zhang, Y; Zhou, Q; Zhou, Y; Zhu, H1

Other Studies

1 other study(ies) available for butenolide and Carcinoma, Pancreatic Ductal

ArticleYear
Butenolides from a marine-derived fungus Aspergillus terreus with antitumor activities against pancreatic ductal adenocarcinoma cells.
    Bioorganic & medicinal chemistry, 2018, 12-01, Volume: 26, Issue:22

    Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Aspergillus; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pancreatic Neoplasms; Structure-Activity Relationship

2018